APA

van den Bent M., Azaro A., De Vos F., Sepulveda J., Yung W. K. A., Wen P. Y., Lassman A. B., Joerger M., Tabatabai G., Rodon J., Tiedt R., Zhao S., Kirsilae T., Cheng Y., Vicente S., Balbin O. A., Zhang H. & Wick W. (20200609). A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma. : Journal of neuro-oncology.

Chicago

van den Bent Martin, Azaro Analia, De Vos Filip, Sepulveda Juan, Yung W K Alfred, Wen Patrick Y, Lassman Andrew B, Joerger Markus, Tabatabai Ghazaleh, Rodon Jordi, Tiedt Ralph, Zhao Sylvia, Kirsilae Tiina, Cheng Yi, Vicente Sergio, Balbin O Alejandro, Zhang Hefei and Wick Wolfgang. 20200609. A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma. : Journal of neuro-oncology.

Harvard

van den Bent M., Azaro A., De Vos F., Sepulveda J., Yung W. K. A., Wen P. Y., Lassman A. B., Joerger M., Tabatabai G., Rodon J., Tiedt R., Zhao S., Kirsilae T., Cheng Y., Vicente S., Balbin O. A., Zhang H. and Wick W. (20200609). A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma. : Journal of neuro-oncology.

MLA

van den Bent Martin, Azaro Analia, De Vos Filip, Sepulveda Juan, Yung W K Alfred, Wen Patrick Y, Lassman Andrew B, Joerger Markus, Tabatabai Ghazaleh, Rodon Jordi, Tiedt Ralph, Zhao Sylvia, Kirsilae Tiina, Cheng Yi, Vicente Sergio, Balbin O Alejandro, Zhang Hefei and Wick Wolfgang. A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma. : Journal of neuro-oncology. 20200609.